نتائج البحث - Moehler, Markus
- يعرض 1 - 20 نتائج من 70
- اذهب إلى الاصفحة التالية
-
1
-
2
-
3
-
4
-
5
Rational Combination of Parvovirus H1 With CTLA-4 and PD-1 Checkpoint Inhibitors Dampens the Tumor Induced Immune Silencing حسب Goepfert, Katrin, Dinsart, Christiane, Rommelaere, Jean, Foerster, Friedrich, Moehler, Markus
منشور في 2019نص -
6
-
7
-
8
Influence of the oncolytic parvovirus H-1, CTLA-4 antibody tremelimumab and cytostatic drugs on the human immune system in a human in vitro model of colorectal cancer cells حسب Heinrich, Bernd, Goepfert, Katrin, Delic, Maike, Galle, Peter R, Moehler, Markus
منشور في 2013نص -
9
-
10
Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immune checkpoint inhibitors for first‐ or second‐line treatment of advanced gastric and gastro‐esophageal jun... حسب Özdemir, Berna C, Moehler, Markus, Syn, Nicholas LX, Tai, Bee‐Choo, Wagner, Anna Dorothea
منشور في 2019نص -
11
-
12
Survival after chemotherapy and/or radiotherapy versus self-expanding metal stent insertion in the setting of inoperable esophageal cancer: a case-control study حسب Sgourakis, George, Gockel, Ines, Karaliotas, Constantine, Moehler, Markus, Schimanski, Carl Christoph, Schmidberger, Heinz, Junginger, Theodor
منشور في 2012نص -
13
Combination therapies with oxaliplatin and oral capecitabine or intravenous 5-FU show similar toxicity profiles in gastrointestinal carcinoma patients if hand-food syndrome prophyl... حسب WEHLER, THOMAS C., CAO, YANG, GALLE, PETER R., THEOBALD, MATTHIAS, MOEHLER, MARKUS, SCHIMANSKI, CARL C.
منشور في 2012نص -
14
Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report حسب Sprinzl, Martin F, Schimanski, Carl C, Moehler, Markus, Schadmand-Fischer, Simin, Galle, Peter R, Kanzler, Stephan
منشور في 2006نص -
15
Oncolytic Virotherapy as Emerging Immunotherapeutic Modality: Potential of Parvovirus H-1 حسب Moehler, Markus, Goepfert, Katrin, Heinrich, Bernd, Breitbach, Caroline J., Delic, Maike, Galle, Peter Robert, Rommelaere, Jean
منشور في 2014نص -
16
Any progress in informed consenting for cancer treatment? Results from a cross sectional analysis at a comprehensive cancer center حسب Schwaegermann, Marie-Kristin, Schranz, Melanie, Moehler, Markus, Labenz, Christian, Moringlane, Alice, Schmidt, Marcus, Theobald, Matthias, Hess, Georg
منشور في 2021نص -
17
High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells حسب Schimanski, Carl Christoph, Frerichs, Kirsten, Rahman, Fareed, Berger, Martin, Lang, Hauke, Galle, Peter R, Moehler, Markus, Gockel, Ines
منشور في 2009نص -
18
VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab حسب Moehler, Markus, Frings, Christian, Mueller, Annett, Gockel, Ines, Schimanski, Carl C, Biesterfeld, Stefan, Galle, Peter R, Holtmann, Martin H
منشور في 2008نص -
19
Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1 حسب Moehler, Markus, Sieben, Maike, Roth, Susanne, Springsguth, Franziska, Leuchs, Barbara, Zeidler, Maja, Dinsart, Christiane, Rommelaere, Jean, Galle, Peter R
منشور في 2011نص -
20
Advances in the endoscopic management of malignant biliary obstruction حسب Thomaidis, Thomas, Kallimanis, George, May, Gary, Zhou, Pinghong, Sivanathan, Visvakanth, Mosko, Jeff, Triantafillidis, John K., Teshima, Christopher, Moehler, Markus
منشور في 2020نص